A novel peptide-templated AgNPs nanoprobe for theranostics of prostate cancer

Biosens Bioelectron. 2023 Mar 1:223:114978. doi: 10.1016/j.bios.2022.114978. Epub 2022 Dec 16.

Abstract

Prostate specific membrane antigen (PSMA)-positive exosomes have the potential to serve as highly sensitive biomarkers for prostate cancer detection. Herein, a sensitive electrochemical biosensor for the ultrasensitive detection of PSMA-positive exosomes has been constructed based on a peptide-templated AgNPs nanoprobe. In this work, PSMA-specific binding peptides immobilized on a gold electrode were responsible for prostate cancer-derived exosomes capturing. Well-designed peptide (CCY- LWYIKC) serves a dual role: as a signal probe and as a recognizer in the exosomes-identification process. Specifically, LWYIKC bind to cholesterol at the exosome membranes, and CCY function as peptide templates to host a large number of silver nanoparticles, leading to a strong electrochemical signal. Thus, the concentration of exosomes can be quantified via electrochemical signal. This innovative method displayed a wide detection range of 102 to 108 particles/μL and a detection limit as low as 37 particles/μL. Notably, the method has shown outstanding performance when validated using clinical samples, suggesting its potential for clinical applications.

Keywords: Electrochemical signal amplification; PSMA-Positive exosomes; Peptide-templated AgNPs nanoprobe; Prostate cancer.

MeSH terms

  • Biosensing Techniques* / methods
  • Electrochemical Techniques / methods
  • Exosomes*
  • Gold
  • Humans
  • Limit of Detection
  • Male
  • Metal Nanoparticles*
  • Peptides
  • Precision Medicine
  • Prostatic Neoplasms* / diagnosis
  • Silver

Substances

  • Silver
  • Peptides
  • Gold